Nisunate 50mg Tablet
Manufacturer
Neiss Labs Pvt Ltd
Salt Composition
Artesunate (50mg)
Key Information
Short Description
Nisunate 50mg Tablet is an antiparasitic medication used in the treatment of malaria. It is not used to prevent malaria or to treat severe malaria.
Dosage Form
Tablet
Introduction
Nisunate 50mg Tablet should be used in the dose and duration as advised by your doctor. Take it with food, preferably at a fixed time. Do not skip any doses and finish the full course of treatment even if you feel better. Do not take a double dose to make up for a missed dose. Some people may experience a headache, weakness, and loss of appetite as side effects. Please consult your doctor if these side effects persist. You may be monitored with blood tests once a week for 4 weeks to detect the presence of malarial parasites.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Nisunate 50mg Tablet is to be taken with food.
How it works
Nisunate 50mg Tablet is an antiparasitic medication. It works by producing harmful chemicals (free radicals) within the malarial parasite, thereby killing it.
Quick Tips
Nisunate 50mg Tablet is used in the treatment of malaria. Inform your doctor if you are allergic to Nisunate 50mg Tablet. Do not drive or operate machinery after taking it because you may feel sleepy. Nisunate 50mg Tablet should be taken with food or drinks enriched with fat such as milk. Do not skip any doses and finish the full course of treatment even if you feel better. It may cause dizziness and sleepiness. Use caution while driving or doing anything that requires concentration. Do not take this medicine if you are in the first 3 months of pregnancy. Inform your doctor if you are breastfeeding. Inform your doctor if you notice flu-like symptoms such as chills, fever, muscle pains, and any changes in a heartbeat. You may be asked for a regular blood test once a week while taking this medicine.
Related Medicines
Arteun 50mg Tablet
Grasun 50mg Tablet
Malwin 50mg Tablet
Rtsunate 50mg Tablet
Tesuka 50mg Tablet
Ni Sunate 50mg Tablet
Artfin 50mg Tablet
Arsu 50mg Tablet
Falno 50mg Tablet
Falcimax 50mg Tablet
Frequently asked questions
Who should not use Nisunate 50mg Tablet?
Nisunate 50mg Tablet should not be used by patients who are allergic to Nisunate 50mg Tablet or any of its components. If you are unaware of any allergies or if you are using Nisunate 50mg Tablet for the first time, consult your doctor before use.
What should I tell my doctor before starting treatment with Nisunate 50mg Tablet?
Before starting treatment with Nisunate 50mg Tablet, inform your doctor if you have any other health conditions like kidney- or heart-related problems. This is because certain medical conditions may affect your treatment and you may even need dose modifications. Also, let your doctor know about all the other medicines you are taking because they may affect, or be affected by, this medicine. Inform your doctor if you are pregnant or breastfeeding.
Is Nisunate 50mg Tablet safe?
Nisunate 50mg Tablet is generally safe when used in the dose and duration prescribed by your doctor. Take it exactly as directed and do not skip any doses. Follow your doctor's instructions carefully and let your doctor know if you experience any side effects.
What if I forget to take a dose of Nisunate 50mg Tablet?
If you forget a dose of Nisunate 50mg Tablet, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and take the next scheduled dose in the prescribed time. Do not double the dose to make up for the missed one as this may increase the chances of developing side effects.
Can I stop taking Nisunate 50mg Tablet when I feel better?
No, do not stop taking Nisunate 50mg Tablet without consulting your doctor even if you are feeling better. Your symptoms may improve before the infection is completely cured. Therefore, for better and complete treatment, it is advised to continue your treatment for the prescribed duration.
